BR0315178A - Eritropoietina: remodelagem e glicoconjugação de eritropoietina - Google Patents

Eritropoietina: remodelagem e glicoconjugação de eritropoietina

Info

Publication number
BR0315178A
BR0315178A BR0315178-6A BR0315178A BR0315178A BR 0315178 A BR0315178 A BR 0315178A BR 0315178 A BR0315178 A BR 0315178A BR 0315178 A BR0315178 A BR 0315178A
Authority
BR
Brazil
Prior art keywords
erythropoietin
remodeling
glycoconjugation
peptide
deleting
Prior art date
Application number
BR0315178-6A
Other languages
English (en)
Inventor
Shawn Defrees
David Zopf
Robert Bayer
David Hakes
Caryn Bowe
Xi Chen
Original Assignee
Neose Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2002/032263 external-priority patent/WO2003031464A2/en
Priority claimed from US10/410,945 external-priority patent/US7214660B2/en
Application filed by Neose Technologies Inc filed Critical Neose Technologies Inc
Publication of BR0315178A publication Critical patent/BR0315178A/pt

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"ERITROPOIETINA: REMODELAGEM E GLICOCONJUGAçãO DE ERITROPOIETINA". A invenção inclui métodos e composições para a remodelagem uma molécula de peptídeo, que inclui a adição ou deleção de um ou mais grupos glicosil a um peptídeo, e/ou a adição de um grupo de modificação ao peptídeo.
BR0315178-6A 2002-10-09 2003-10-08 Eritropoietina: remodelagem e glicoconjugação de eritropoietina BR0315178A (pt)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
PCT/US2002/032263 WO2003031464A2 (en) 2001-10-10 2002-10-09 Remodeling and glycoconjugation of peptides
US10/287,994 US7138371B2 (en) 2001-10-10 2002-11-05 Remodeling and glycoconjugation of peptides
US36077003A 2003-01-06 2003-01-06
US36077903A 2003-02-19 2003-02-19
US10/410,945 US7214660B2 (en) 2001-10-10 2003-04-09 Erythropoietin: remodeling and glycoconjugation of erythropoietin
PCT/US2003/031974 WO2004033651A2 (en) 2002-10-09 2003-10-08 Erythropoietin: remodeling and glycoconjugation of erythropoietin

Publications (1)

Publication Number Publication Date
BR0315178A true BR0315178A (pt) 2005-08-16

Family

ID=34841934

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0315178-6A BR0315178A (pt) 2002-10-09 2003-10-08 Eritropoietina: remodelagem e glicoconjugação de eritropoietina

Country Status (2)

Country Link
BR (1) BR0315178A (pt)
NZ (1) NZ539415A (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7214660B2 (en) 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
PL1615945T3 (pl) 2003-04-09 2012-03-30 Ratiopharm Gmbh Sposoby glikopegylacji i białka/peptydy wytwarzane tymi sposobami
US9005625B2 (en) 2003-07-25 2015-04-14 Novo Nordisk A/S Antibody toxin conjugates
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
US20080300173A1 (en) 2004-07-13 2008-12-04 Defrees Shawn Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1]
WO2006050247A2 (en) 2004-10-29 2006-05-11 Neose Technologies, Inc. Remodeling and glycopegylation of fibroblast growth factor (fgf)
US9029331B2 (en) 2005-01-10 2015-05-12 Novo Nordisk A/S Glycopegylated granulocyte colony stimulating factor
WO2006121569A2 (en) 2005-04-08 2006-11-16 Neose Technologies, Inc. Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
US20070105755A1 (en) 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
WO2007056191A2 (en) 2005-11-03 2007-05-18 Neose Technologies, Inc. Nucleotide sugar purification using membranes
EP2049144B8 (en) 2006-07-21 2015-02-18 ratiopharm GmbH Glycosylation of peptides via o-linked glycosylation sequences
EP2054521A4 (en) 2006-10-03 2012-12-19 Novo Nordisk As PROCESS FOR CLEANING POLYPEPTIDE CONJUGATES
HRP20130382T1 (hr) 2007-04-03 2013-05-31 Biogenerix Ag Postupci lijeäśenja pomoä†u glikopegiliranog g-csf
CA2690611C (en) 2007-06-12 2015-12-08 Novo Nordisk A/S Improved process for the production of nucleotide sugars
PL2257311T3 (pl) 2008-02-27 2014-09-30 Novo Nordisk As Koniugaty cząsteczek czynnika VIII

Also Published As

Publication number Publication date
NZ539415A (en) 2008-12-24

Similar Documents

Publication Publication Date Title
BR0213207A (pt) remodelagem e glicoconjugação de peptìdeos
MXPA05003730A (es) Eritropoyetina: remodelado y glicoconjugacion de eritropoyetina.
BR0315178A (pt) Eritropoietina: remodelagem e glicoconjugação de eritropoietina
WO2004099231A3 (en) Glycopegylation methods and proteins/peptides produced by the methods
BR0108713A (pt) Expressão hìbrida de proteìnas de neisseria
CY1124802T1 (el) Δεσμευτικοι παραγοντες σκληροστινης
BRPI0311516A8 (pt) Composição de xampu de condicionamento e seu método de preparo
DK2207786T3 (da) 2´-Fluor-2´-deoxytetrahydrouridiner som cytidindeaminasehæmmere
BR0315275A (pt) Anticorpos que se ligam a receptor de eritropoietina
BR0317822A (pt) Composição fluoroquìmica
ECSP099027A (es) Anticuerpos anti-dll4 y métodos que los usan
CY1106366T1 (el) Ενωση λακταμης για την αναστολη της απελευθερωσης ή της συνθεσης βητα-αμυλοειδους πεπτιδιου
BRPI0601896A (pt) composições que contêm microgéis e agentes espessantes
ATE253063T1 (de) 5-ht1f-agonisten
PE20081392A1 (es) Moleculas de enlace de lingo
CY1109465T1 (el) Νεες φαρμακευτικες φαρμακοτεχνικες μορφες μονταφινιλης
BR0003072A (pt) Fechadura de cilindro dotada de meios de orientação magneticamente operados
DK1383919T3 (da) Fremgangsmåder og sammensætninger til anvendelse af MHC klasse II-invariant kædepolypeptid som en receptor for makrofag migrationsinhiberede faktor
EA200500899A1 (ru) Антагонисты аденозиндифосфатного рецептора тромбоцитов
BR0317284A (pt) Inibidores aminocianopiridina de proteìna quinase-2 ativada com proteìna quinase ativada com mitógeno
CY1114532T1 (el) (2r)-2-[(4-σουλφονυλ)αμινοφαινυλ]προπαναμιδια και φαρμακευτικες συνθεσεις περιεχοντας τα
BR9909805A (pt) Certos inibidores de tiol de enzima de conversão de endotelina
EA200600590A1 (ru) Фармацевтические композиции модафинила с модифицированным высвобождением
TR200002955T2 (tr) Antitümör aktivitesi olan spisülozin bileşimleri
BRPI0415450A (pt) composições de antibióticos

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: BIOGENERIX AG (DE)

Free format text: TRANSFERIDO DE: NEOSE TECHNOLOGIES, INC.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25G Requested change of headquarter approved

Owner name: BIOGENERIX AG (DE)

B25D Requested change of name of applicant approved

Owner name: BIOGENERIX GMBH (DE)

B25A Requested transfer of rights approved

Owner name: RATIOPHARM GMBH (DE)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2483 DE 07-08-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.